Hinge Health Inc. (NYSE:HNGE - Get Free Report) was the target of some unusual options trading on Monday. Stock traders acquired 6,399 call options on the company. This represents an increase of approximately 465% compared to the average volume of 1,132 call options.
Analyst Ratings Changes
HNGE has been the subject of a number of recent research reports. Evercore ISI assumed coverage on Hinge Health in a research report on Monday, June 16th. They issued an "outperform" rating and a $50.00 target price for the company. Raymond James Financial began coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued an "outperform" rating and a $45.00 price objective for the company. Bank of America started coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued a "buy" rating and a $42.00 target price on the stock. Truist Financial started coverage on shares of Hinge Health in a research report on Monday, June 16th. They set a "buy" rating and a $48.00 price target for the company. Finally, Needham & Company LLC initiated coverage on Hinge Health in a report on Monday, June 16th. They set a "buy" rating and a $47.00 target price for the company. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to data from MarketBeat, Hinge Health has a consensus rating of "Moderate Buy" and a consensus price target of $46.00.
Get Our Latest Stock Report on Hinge Health
Hinge Health Stock Performance
NYSE HNGE traded up $0.34 during trading on Thursday, hitting $44.87. The company had a trading volume of 1,137,814 shares, compared to its average volume of 766,036. Hinge Health has a one year low of $33.42 and a one year high of $48.85.
Hinge Health Company Profile
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Recommended Stories
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.